Press release
Breast Implants Market to Grow at a CAGR of 7.00% Through 2032 - Insights, Competitive Landscape, and Forecast | DelveInsight
Breast Implants Market
DelveInsight's Breast Implants Market Insights report delivers comprehensive market analysis, competitive landscape overview, key growth drivers and challenges, and detailed profiles of leading players. The report provides stakeholders with valuable insights to strategically navigate and capitalize on the evolving breast implants market.
Explore the latest trends and growth drivers in the breast implants Market-download your sample report now https://www.delveinsight.com/report-store/breast-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Key Takeaways from the Breast Implants Market Report
• The global breast implants market was valued at USD 35.21 billion in 2023 and is projected to reach USD 56.46 billion by 2032, growing at a CAGR of 8.20% during the forecast period (2025-2032).
• As per DelveInsight estimates, North America is anticipated to dominate the global breast implants market during the forecast period.
• Notable Breast Implants companies such as Johnson & Johnson Services, Inc., Hans BioMed., AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and several others are currently operating in the breast implants market.
• In December 2024, Mentor Worldwide LLC, a Johnson & Johnson MedTech company, received FDA approval for its MENTORTM MemoryGelTM Enhance Breast Implants for use in primary and revision reconstruction after mastectomy. This new silicone gel implant line offers the largest size range on the market (930 cc to 1445 cc) and will launch in the U.S. in mid-2025.
• In September 2024, Establishment Labs Holdings Inc. (NASDAQ: ESTA) received FDA approval for its Motiva® SmoothSilk® Ergonomix® and SmoothSilk® Round breast implants for use in primary and revision breast augmentation procedures.
• In April 2024, GC Aesthetics, a leading designer, manufacturer, and distributor of breast implants and medical devices for the global aesthetics industry, announced the micro-textured anatomical breast implant LUNA XT. It is the first breast implant in the world approved under the new European Medical Device Regulation (MDR).
To read more about the latest highlights related to the breast implants market, get a snapshot of the key highlights entailed in the global breast implants market report here https://www.delveinsight.com/report-store/breast-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Breast Implants Overview
Breast implants are medical devices used to enhance breast size, restore breast volume after weight reduction or pregnancy, or reconstruct the breast following mastectomy or injury. They are commonly used in both cosmetic and reconstructive surgeries. The two primary types of breast implants are saline-filled and silicone gel-filled, each with different shapes, sizes, textures, and profiles to meet individual patient needs. Technological advancements have led to more natural-feeling and safer implants, such as form-stable (gummy bear) implants and smooth-surface designs. The breast implants market continues to grow due to rising demand for aesthetic procedures, increasing awareness of reconstruction options after breast cancer, and innovations improving implant durability and patient outcomes.
Breast Implants Market Insights
North America is expected to hold a major share in the breast implants market from 2025 to 2032, driven by the rising number of cosmetic and reconstructive breast surgeries, high breast cancer prevalence, and continuous technological advancements. According to the American Society of Plastic Surgeons (2024), over 304,000 breast augmentation and 157,000 reconstruction procedures were performed in the U.S. in 2022. Globocan 2024 also reported over 274,000 breast cancer cases in the U.S. and 31,000 in Canada the same year-driving demand for post-treatment reconstruction. Additionally, product launches and awareness campaigns by key players like AbbVie are contributing to market growth.
To know more about why North America is leading the market growth in the breast implants market, get a snapshot of the breast implants market outlook here https://www.delveinsight.com/report-store/breast-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Breast Implants Market Dynamics
According to Globocan 2024, breast cancer affected approximately 2,296,840 people globally, with Asia reporting 985,817 cases, Europe 557,532, and Africa 198,553. The high incidence of breast cancer is increasing demand for breast reconstruction options, including implants, as many patients opt for post-mastectomy surgery. This trend is expanding the breast implants market by supporting survivors' physical and emotional recovery.
Product innovation by key players is also driving market growth. For example, in September 2024, GC Aesthetics® launched its YOUTHLYTM brand in China, featuring advanced implants like PERLETM, Luna XTTM, and the fully filled Round CollectionTM. In August 2024, CollPlant and Stratasys announced a pre-clinical study of 3D-printed regenerative breast implants, marking a significant development in the field.
Despite these positive factors, challenges such as potential risks related to implants and the high cost of augmentation procedures may limit growth in the breast implants market during the forecast period from 2025 to 2032.
However, the high cost of Breast Implants remains a key challenge that could limit wider adoption globally.
Get a sneak peek at the breast implants market dynamics @ https://www.delveinsight.com/report-store/breast-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Coverage: Global
Study Period: 2022 to 2032
Breast Implants Market CAGR: ~7.00%
Key Breast Implants Companies: Johnson & Johnson Services, Inc., Hans BioMed., AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and others.
Breast Implants Market Segmentation
Market Segmentation By Product Type: Silicone Breast Implants and Saline Breast Implants.
Market Segmentation By Shape: Round and Anatomical.
Market Segmentation By Texture: Smooth and Textured.
Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers,
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the breast implants market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/breast-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. Breast Implants Market Report Introduction
2. Breast Implants Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Breast Implants Market Key Factors Analysis
6. Breast Implants Market Porter's Five Forces Analysis
7. Breast Implants Market Layout
8. Breast Implants Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Implants Market to Grow at a CAGR of 7.00% Through 2032 - Insights, Competitive Landscape, and Forecast | DelveInsight here
News-ID: 4052311 • Views: …
More Releases from DelveInsight
Insulin Resistance Pipeline Insight 2025: Pipeline Drugs, Metabolic Pathway Modu …
DelveInsight's "Insulin Resistance - Pipeline Insight, 2025" explores over 10+ therapies in development for insulin resistance, a metabolic condition strongly linked to type 2 diabetes, obesity, and cardiovascular disease. Despite lifestyle modification and insulin-sensitizing drugs like metformin being mainstays of management, many patients continue to face poor glycemic control and associated complications, underscoring the need for more effective insulin resistance treatments.
The insulin resistance pipeline is broadening with next-generation therapies targeting…
Uveal Melanoma Pipeline Insight 2025: 30+ Pipeline Drugs, Targeted Therapies, an …
DelveInsight's "Uveal Melanoma - Pipeline Insight, 2025" explores over 30+ therapies in development for uveal melanoma, a rare and aggressive intraocular malignancy with high metastatic potential, most commonly to the liver. Despite surgery and radiotherapy being standards for localized disease, patients with metastatic uveal melanoma face limited systemic treatment options, creating significant unmet needs in the uveal melanoma treatment landscape.
The uveal melanoma pipeline is diversifying with next-generation targeted therapies, including…
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,…
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trial …
DelveInsight's "Vaso-Occlusive Crisis (VOC) Associated With Sickle Cell Disease - Pipeline Insight, 2025" provides an in-depth analysis of emerging therapies targeting vaso-occlusive crisis (VOC), a severe and recurring complication of sickle cell disease. Despite current standards of care, including hydroxyurea, patients continue to experience frequent vaso occlusive sickle cell crisis, underscoring the urgent need for effective interventions in sickle cell anemia vaso occlusive crisis treatment.
The VOC pipeline is diversifying with…
More Releases for Breast
Breast Health Monitoring App Market to Witness a Pronounce Growth during 2024-20 …
The latest market intelligence report published by WMR with the title "Global Breast Health Monitoring App Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Healthcare and Pharmaceuticals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Breast Health Monitoring App Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y…
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer …
FOR IMMEDIATE RELEASE
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer During Breast Cancer Awareness Month
Liverpool, UK - October, 2023 - Phil Alderson, a primary survivor of male breast cancer, is taking bold steps this Breast Cancer Awareness Month to raise awareness of this often overlooked aspect of the disease. With a homemade cardboard sign that reads "Check Your Pecks," Phil has taken to the streets of…
Breast Health Monitoring App Market Recent Trends, In-depth Analysis, Size, and …
According to The Worldwide Market Reports, the Latest research report on "Breast Health Monitoring App Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Breast Health Monitoring App Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore,…
Breast Pumps Market - Nurturing Convenience: Revolutionizing Breast Pump Technol …
Newark, New Castle, USA - new report, titled Breast Pumps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Breast Pumps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Breast Pumps market. The report offers an overview of the market, which…
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues.
Download Free PDF Brochure on Brest Imaging Market Report Now…
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to…
